N-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119
Zhi‐Liang Chu(Arena Pharmaceuticals (United States)), James Leonard(Arena Pharmaceuticals (United States)), Robert M. Jones(Arena Pharmaceuticals (United States)), Hongmei He(Arena Pharmaceuticals (United States)), Charles Xing(Arena Pharmaceuticals (United States)), Brandee Wagner(Duke Medical Center), David J. Unett(Arena Pharmaceuticals (United States)), Kristen Sebring(Arena Pharmaceuticals (United States)), Verónica Gutiérrez(Universidad de la República de Uruguay), Dominic P. Behan, Ruoping Chen(Arena Pharmaceuticals (United States)), Jean Alfonso(Arena Pharmaceuticals (United States)), Annette Lucman(Arena Pharmaceuticals (United States)), Jinyao Zhou(Guiyang Medical University), Christopher J. Carroll(St George's, University of London)
Cited by 126
Related Papers
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
|Endocrinology|2008|382
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury
|Journal of Molecular and Cellular Cardiology|2006|312
Mitochondrial myopathy induces a starvation-like response
|Human Molecular Genetics|2010|306